9 – 10 March 2022

The greatest event around excipients is coming back in March 2022!

Be excited for the next incredible


More news are coming soon!

Until then, stay safe, stay healthy and all the best!

teaser ExciPerience 2022 - SAVE THE DATE

What is the ExciPerience?

It is a new way of virtual event experience for pharmaceutical excipients. It combines excipients knowledge transfer with a new communication experience.





Why you should participate as a visitor?

Your participation in the ExciPerience gives you three main chances!





Why you should participate as an exhibitor and sponsor?

ExciPerience will be a completely new event experience and fully focussed on all the topics around pharmaceutical excipients. There are several possibilities for you as an exhibitor to get in contact with the participants.




What is the ExciPerience?

Exciperience is the new virtual event around every aspect of pharmaceutical excipients. By Pharma Excipients – the main digital source for information and transaction of pharmaceutical excipients for many years now. Following our mission to give pharmaceutical excipients a bigger awareness and to broaden the knowledge on excipients.

Exciperience covers all areas from basic or advanced research and formulation to manufacturing and regulatory. It will be the intersection between all the different perspectives and people in the excipient community. Exciperience gives an exceptional virtual event experience. There will be more and new possibilities for personal interaction and different presentation formats than you are used to.

See the short introduction from Philippe Tschopp

Why you should participate?

Your participation in the exciperience gives you three main chances: 


You have a lot of possibilities for interaction – with people of the pharma excipients community from all over the world


You expand and broaden your pharmaceutical excipients knowledge and get a chance to meet new suppliers and customers


You get to know innovative product solutions for various formulation challenges and new technical possibilities